Breathlessness Perceptions Within Respiratory Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity Hospitals, Leicester

About this trial

Breathlessness is a complex symptom that results in poor quality of life, increased hospitalisations and increased mortality. Breathlessness is influenced by physiological, psychological and functional factors but these are poorly explored. There are also unexplored phenomenon's such as breathing pattern. Therefore, this study aims to understand the influences of physiology, psychology, function and breathing pattern on health related quality of life in those with a respiratory disease compared to healthy controls. This project is a cross-sectional cohort study including those with a known respiratory disease and experiencing breathlessness, compared to non-breathless healthy controls. The investigators will measure your physiology through spirometry (a breathing test that tells us about their lung function), psychology through questionnaires, function through an exercise test and breathing pattern using opto-electrictronic plethysmography (markers are placed on your chest to see how participants breathe while exercising). This will be conducted over two visits. The investigators will recruit participants from clinics at the University Hospitals of Leicester NHS Trust. The investigators are aiming to recruit 50 participants with a respiratory disease and 25 healthy controls. The results of this study will help us understand breathlessness in more detail in order to be able to develop better treatments.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

• Aged 18 or over up to 100

Known respiratory diagnosis* OR Healthy control**

Ongoing symptoms of breathlessness defined as ≥2 MRC dyspnoea scale

Able to communicate in English

Disqualifiers

• Unstable disease or undergoing investigations for unexplained symptoms

Undergone a surgery within past six weeks

Contraindications for exercise outlined by ACSM guidelines (Unstable CVD, hypertension etc)

BMI ≥ 35kg/m2

Trial population

The study population consists of a healthy group and a disease group. The disease group will have a known respiratory condition such as COPD, Asthma, ILD or Bronchiectasis. The healthy group will not have any functionally limiting conditions interms, cardiorespiratory and muskuloskeletal.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Not listed

Trial groups

75 Participants
are grouped into 1 trial group
Group A: 50 participants with a respiratory disease and 25 health controls will be recruited.

Trial outcomes

Primary outcomes

1

Breathing pattern regional contribution parameters

Optoelectronic plethysmography allows to quantify how different thoracic compartments contribute to the overall tidal volume through regional contribution parameters. These regional contributions are expressed as percentages.

Time frame
From June 2025 to July 2026

Secondary outcomes

1

Breathing pattern-Timing parameters-Recording duration

The duration will be recorded in minutes and seconds to state how long a specific measurement lasted.

Time frame
From June 2025 to July 2026
2

Breathing pattern-Timing parameters- Sampling frequency rate

This is one of the core timing parameter. The system uses sample at 60-120 Hz (frames per second).

Time frame
From June 2025 to July 2026
3

Breathing pattern-Timing Parameters- Number of respiratory cycles analysed

This parameter is important to give an indication of data adequacy. It will be reported in whole numbers.

Time frame
From June 2025 to July 2026
4

Breathing pattern-Ratio parameters-Compartmental contributions

All the parameters will be expressed as percentages. (%RCp, %RCa and %AB) typically ranging from (0-100%)

Time frame
From June 2025 to July 2026

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.